Walvax Biotechnology Co., Ltd. (SHE:300142)

China · Delayed Price · Currency is CNY

12.09

-0.08 (-0.66%)

Feb 24, 2026, 10:05 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Technical Service	201.21M		16.55M	-	-	-
Other	17.86M		7.65M	10.50M	-	-
Other Growth	-		-27.15%	-	-	-
Autonomous Vaccine	2.54B		5.04B	3.43B	-	-
Autonomous Vaccine Growth	-		46.86%	-	-	-
Intermediate Products	60.26M		27.16M	23.88M	-	-
Intermediate Products Growth	-		13.76%	-	-	-
Production Division	-		-	-	2.95B	1.13B
Production Division Growth	-		-	-	162.16%	29.98%
Research and Development (R&D) Division	-		-	-	131.45M	8.29M
Research and Development (R&D) Division Growth	-		-	-	1485.09%	-80.12%
Offset of Business Segment	-		-	-	-145.47M	-13.52M
Technical Services	-		-	45.28K	-	-
Total	2.82B		5.09B	3.46B	2.94B	1.12B
Total Growth	-		46.89%	17.82%	162.13%	27.55%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Northeast China	252.42M		567.36M	365.48M	468.11M	103.55M
Northeast China Growth	-		55.24%	-21.93%	352.06%	42.29%
Eastern China	874.69M		1.71B	1.31B	842.60M	353.34M
Eastern China Growth	-		30.69%	55.26%	138.47%	21.72%
South China Region	404.62M		838.37M	518.34M	427.54M	202.53M
South China Region Growth	-		61.74%	21.24%	111.10%	29.36%
Central China Region	332.25M		771.53M	637.01M	713.32M	171.86M
Central China Region Growth	-		21.12%	-10.70%	315.05%	31.09%
Southwest Northwest Region	387.18M		916.10M	567.95M	530.09M	207.24M
Southwest Northwest Region Growth	-		61.30%	7.14%	155.79%	4.26%
Overseas Region	570.29M		283.41M	65.87M	102.83M	96.21M
Overseas Region Growth	-		330.25%	-35.94%	6.88%	63.60%
Intersegment Offset	-		-	-	-145.47M	-13.52M
Total	2.82B		5.09B	3.46B	2.94B	1.12B
Total Growth	-		46.89%	17.82%	162.13%	27.55%

Source: S&P Global Market Intelligence.